Suppression of prostate epithelial proliferation and intraprostatic progrowth signaling in transgenic mice by a new energy restriction-mimetic agent

Cancer Prevention Research

Volumn 6, Issue 3, 2013, Pages 232-241

  Berman Booty, Lisa D ^a   Chu, Po Chen ^a   Thomas Ahner, Jennifer M ^b   Bolon, Brad ^a,c   Wang, Dasheng ^a   Yang, Tiffany ^a   Clinton, Steven K ^b   Kulp, Samuel K ^a   Chen, Ching Shih ^a,d  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Veterinary Biosciences   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; CYCLINE; KI 67 ANTIGEN; OSU CG 5; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENERGY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE WEIGHT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLYCOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 84877299136     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0057     Document Type: Article

References (39)

1. Chesney J. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 2006;9:535-9. (Pubitemid 44258026)
2. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
3. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82. (Pubitemid 351766797)
4. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006;66:8927-30. (Pubitemid 44521105)
5. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.
6. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008;134:703-7.
7. Kaelin WG Jr, Thompson CB. Q&A: Cancer: clues from cell metabolism. Nature 2010;465:562-4.
8. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Toxicol Sci 1999;52:13-6. (Pubitemid 30017570)
9. Jiang W, Zhu Z, Thompson HJ. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res 2008;68:5492-9.
10. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-52. (Pubitemid 37386388)
11. Berrigan D, Perkins SN, Haines DC, Hursting SD. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 2002;23:817-22. (Pubitemid 34567521)
12. Mukherjee P, Sotnikov AV, Mangian HJ, Zhou JR, Visek WJ, Clinton SK. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 1999; 91:512-23. (Pubitemid 29157059)
13. Kaplan-Lefko PJ, Chen TM, Ittman MM, Barrios RJ, Ayala GE, Huss WJ, et al. Pathobiology of autochthonous prostate cancer in a preclinical transgenic mouse model. Prostate 2003;55:219-37. (Pubitemid 36532401)
14. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 1999;2:70-5. (Pubitemid 29259935)
15. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995;92:3439-43.
16. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res 1996;56:4096-102. (Pubitemid 26304996)
17. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, et al. The rat probasin gene promoter directs hormonally- and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 1994;8:230-9. (Pubitemid 24067110)
18. Greenberg NM. Transgenic models for prostate cancer research. Urol Oncol 1996;2:119-22. (Pubitemid 127777118)
19. Berman-Booty LD, Sargeant AM, Rosol TJ, Rengel RC, Clinton SK, Chen CS, et al. A Review of the existing grading schemes and a proposal for a modified grading scheme for prostatic lesions in TRAMP mice. Toxicol Pathol 2012;40:5-17.
20. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, et al. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 2008;172:236-46. (Pubitemid 351186384)
21. Suttie A, Nyska A, Haseman JK, Moser GJ, Hackett TR, Goldsworthy TL. A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model. Toxicol Pathol 2003;31:31-8. (Pubitemid 36169419)
22. Wei S, Kulp SK, Chen CS. Energy restriction as an antitumor target of thiazolidinediones. J Biol Chem 2010;285:9780-91.
23. Wang D, Chu PC, Yang CN, Yan R, Chuang YC, Kulp SK, et al. Development of a novel class of glucose transporter inhibitors. J Med Chem 2012;55:3827-36.
24. Lin HY, Kuo YC, Weng YI, Lai IL, Huang TH, Lin SP, et al. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent. Prostate 2012;72:1767-78.
25. Sargeant AM, Klein RD, Rengel RC, Clinton SK, Kulp SK, Kashida Y, et al. Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer. Toxicol Pathol 2007;35:549-61. (Pubitemid 46911889)
26. Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, et al. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J Biol Chem 2004; 279:40076-83. (Pubitemid 39258282)
27. van Steenbrugge GJ, van Dongen JJ, Reuvers PJ, de Jong FH, Schroeder FH. Transplantable human prostatic carcinoma (PC-82) in athymic nude mice: I. Hormone dependence and the concentration of androgens in plasma and tumor tissue. Prostate 1987;11:195-210.
28. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 2002;21:147-51. (Pubitemid 34756996)
29. Zhu Z, Jiang W, McGinley JN, Thompson HJ. 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res 2005; 65:7023-30. (Pubitemid 41060743)
30. Liao Z, Wang S, Wiegers BS, Clinton SK. Energy balance alters dunning R3327-H prostate tumor architecture, androgen receptor expression, and nuclear morphometry in rats. Prostate 2006;66: 945-53. (Pubitemid 43849593)
31. Fizazi K. The role of Src in prostate cancer. Ann Oncol 2007;18: 1765-73. (Pubitemid 350119560)
32. Omar HA, Berman-Booty L, Kulp SK, Chen CS. Energyrestriction as an antitumor target. Future Oncol 2010;6:1675-9.
33. Suttie AW, Dinse GE, Nyska A, Moser GJ, Goldsworthy TL, Maronpot RR. An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse. Toxicol Pathol 2005;33:386-97. (Pubitemid 40626788)
34. Bonorden MJ, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, et al. Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. Nutr Cancer 2009;61:265-75.
35. Dutt SS, Gao AC. Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncol 2009;5:1403-13.
36. Levay EA, Tammer AH, Penman J, Kent S, Paolini AG. Calorie restriction at increasing levels leads to augmented concentrations of corticosterone and decreasing concentrations of testosterone in rats. Nutr Res 2010;30:366-73.
37. Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 1997;57:4687-91. (Pubitemid 27468967)
38. Blando J, Moore T, Hursting S, Jiang G, Saha A, Beltran L, et al. Dietary energy balance modulates prostate cancer progression in Hi-Myc mice. Cancer Prev Res 2011;4:2002-14.
39. Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascularendothelial growth factorbyprostate adenocarcinomainrats. Mol Carcinog 2008;47:458-65. (Pubitemid 351822304)